Compromised cerebrovascular regulation and cerebral oxygenation in pulmonary arterial hypertension

Journal of the American Heart Association

Volumn 6, Issue 10, 2017, Pages

  Malenfant, Simon ^a,b   Brassard, Patrice ^a,b   Paquette, Myriam ^a,b   Blanc, Olivier Le ^a,b   Chouinard, Audrey ^a,b   Nadeau, Valérie ^a,b   Allan, Philip D ^c   Tzeng, Yu Chieh ^c   Simard, Sébastien ^b   Bonnet, Sébastien ^a,b   Provencher, Steeve ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Central chemoreceptor sensitivity; Cerebral ischemia; Cerebral oxygenation; Cerebrovascular reactivity to CO2; Exercise physiology

Indexed keywords

OXYGEN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BRAIN BLOOD VESSEL; CHEMORECEPTOR; CLINICAL ARTICLE; CONTROLLED STUDY; END TIDAL CARBON DIOXIDE TENSION; EXERCISE; FEMALE; FLOW RATE; HEART OUTPUT; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY; NEAR INFRARED SPECTROSCOPY; OXYGENATION; PHOTOELECTRIC PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REST; BIOLOGICAL MODEL; BLOOD; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; CASE CONTROL STUDY; CHEMORECEPTOR CELL; DIAGNOSTIC IMAGING; EXERCISE TOLERANCE; HEMODYNAMICS; HOMEOSTASIS; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REFLEX; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY;

ADULT; BIOMARKERS; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; CHEMORECEPTOR CELLS; EXERCISE TOLERANCE; FEMALE; HEMODYNAMICS; HOMEOSTASIS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MODELS, CARDIOVASCULAR; OXYGEN; OXYGEN CONSUMPTION; PHOTOPLETHYSMOGRAPHY; REFLEX; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 85032201192     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.006126     Document Type: Article

References (75)

1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk-Noordegraaf A, Beghetti M, Ghofrani A, Gomez-Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Piérard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and the European Respiratory Society. Eur Respir J. 2015;46:903-975.
2. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A metaanalysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009;30:394-403.
3. Lajoie AC, Lauzière G, Lega JC, Lacasse Y, Martin S, Simard S, Bonnet S, Provencher S. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis. Lancet Respir Med. 2016;4:291-305.
4. Rival G, Lacasse Y, Martin S, Bonnet S, Provencher S. Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life. Chest. 2014;146:686-708.
5. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from reveal. Chest. 2012;142:448-456.
6. Bonnet S, Provencher S, Guignabert C, Perros F, Boucherat O, Schermuly RT, Hassoun PM, Rabinovitch M, Nicolls MR, Humbert M. Translating research into improved patient care in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017;195:583-595.
7. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104:429-435.
8. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65:113-117.
9. Batt J, Shadly Ahmed S, Correa J, Bain A, Granton J. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2014;50:74-86.
10. Malenfant S, Potus F, Mainguy V, Leblanc È, Malenfant M, Ribeiro F, Saey D, Maltais F, Bonnet S, Provencher S. Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension. Med Sci Sports Exerc. 2015;47:2273-2282.
11. Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay E, Breuils-Bonnet S, Ribeiro F, Porlier A, Maltais F, Bonnet S, Provencher S. Impaired angiogenesis and peripheral muscle microcirculation loss contributes to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2014;190:318-328.
12. Willie CK, Tzeng YC, Fisher JA, Ainslie PN. Integrative regulation of human brain blood flow. J Physiol. 2014;592:841-859.
13. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, Aldershvile J. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke. 2001;32:2530-2533.
14. Rajagopalan B, Raine AE, Cooper R, Ledingham JG. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am J Med. 1984;76:86-90.
15. Havakuk O, King KS, Grazette L, Yoon AJ, Fong M, Bregman N, Elkayam U, Kloner RA. Heart failure-induced brain injury. J Am Coll Cardiol. 2017;69:1609-1616.
16. Brassard P, Gustafsson F. Exercise intolerance in heart failure: did we forget the brain? Can J Cardiol. 2016;32:475-484.
17. Kim MS, Kim JS, Yun SC, Lee CW, Song JK, Park SW, Park SJ, Kim JJ. Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure. Eur Heart J. 2012;33:354-362.
18. Fraser KS, Heckman GA, McKelvie RS, Harkness K, Middleton LE, Hughson RL. Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: impact of depressed cardiac output. JACC Heart Fail. 2015;3:168-175.
19. Georgiadis D, Sievert M, Cencetti S, Uhlmann F, Krivokuca M, Zierz S, Werdan K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J. 2000;21:407-413.
20. Xie A, Skatrud JB, Khayat R, Dempsey JA, Morgan B, Russell D. Cerebrovascular response to carbon dioxide in patients with congestive heart failure. Am J Respir Crit Care Med. 2005;172:371-378.
21. Erkelens CD, van der Wal HH, de Jong BM, Elting J-W, Renken R, Gerritsen M, van Laar PJ, van Deursen VM, van der Meer P, van Veldhuisen DJ, Voors AA, Luijckx G-J. Dynamics of cerebral blood flow in patients with mild nonischaemic heart failure. Eur J Heart Fail. 2017;19:261-268.
22. Caldas JR, Panerai RB, Haunton VJ, Almeida JP, Ferreira GSR, Camara L, Nogueira RDC, Bor-Seng-Shu E, Oliveira ML, Groehs RRV, Ferreira-Santos L, Teixeira MJ, Galas FRBG, Robinson TG, Jatene FB, Hajjar LA. Cerebral blood flow autoregulation in ischemic heart failure. Am J Physiol Regul Integr Comp Physiol. 2017;312:R108-R113.
23. Rasmussen P, Nielsen J, Overgaard M, Krogh-Madsen R, Gjedde A, Secher NH, Petersen NC. Reduced muscle activation during exercise related to brain oxygenation and metabolism in humans. J Physiol. 2010;588:1985-1995.
24. Fu TC, Wang CH, Hsu CC, Cherng WJ, Huang SC, Wang JS. Suppression of cerebral hemodynamics is associated with reduced functional capacity in patients with heart failure. Am J Physiol Heart Circ Physiol. 2011;300:H1545-H1555.
25. Kim YS, Seifert T, Brassard P, Rasmussen P, Vaag A, Nielsen HB, Secher NH, van Lieshout JJ. Impaired cerebral blood flow and oxygenation during exercise in type 2 diabetic patients. Physiol Rep. 2015;3:e12430.
26. Wensel R, Jilek C, Dörr M, Francis DP, Stadler H, Lange T, Blumberg F, Opitz C, Pfeifer M, Ewert R. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J. 2009;34:895-901.
27. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308-1312.
28. Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29:944-950.
29. Ulrich S, Hasler ED, Saxer S, Furian M, Müller-Mottet S, Keusch S, Bloch KE. Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled crossover trial. Eur Heart J. 2017;38:1159-1168.
30. Treptow E, Oliveira MF, Soares A, Ramos RP, Medina L, Lima R, Alencar MC, Ferreira EV, Ota-Arakaki JS, Tufik S, Nery LE, Bittencourt LR, Neder JA. Cerebral microvascular blood flow and CO2 reactivity in pulmonary arterial hypertension. Respir Physiol Neurobiol. 2016;233:60-65.
31. Willie CK, Colino FL, Bailey DM, Tzeng YC, Binsted G, Jones LW, Haykowsky MJ, Bellapart J, Ogoh S, Smith KJ, Smirl JD, Day TA, Lucas SJ, Eller LK, Ainslie PN. Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function. J Neurosci Methods. 2011;196:221-237.
32. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769-774.
33. Claassen JAHR, Levine BD, Zhang R. Dynamic cerebral autoregulation during repeated squat-stand maneuvers. J Appl Physiol. 2009;106:153-160.
34. Zhang R, ZuckermanJH, GillerCA, LevineBD. Transfer function analysis of dynamic cerebral autoregulation in humans. Am J Physiol. 1998;274:H233-H241.
35. Tzeng YC, Ainslie PN, Cooke WH, Peebles KC, Willie CK, MacRae BA, Smirl JD, Horsman HM, Rickards CA. Assessment of cerebral autoregulation: the quandary of quantification. Am J Physiol Heart Circ Physiol. 2012;303:H658-H671.
36. van Beek AH, Claassen JA, Rikkert MGO, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28:1071-1085.
37. Smirl JD, Hoffman K, Tzeng YC, Hansen A, Ainslie PN. Methodological comparison of active-and passive-driven oscillations in blood pressure: implications for the assessment of cerebral pressure-flow relationships. J Appl Physiol. 2015;119:487-501.
38. Claassen JAHR, Meel-van den Abeelen ASS, Simpson DM, Panerai RB; International Cerebral Autoregulation Research Network (CARNet). Transfer function analysis of dynamic cerebral autoregulation: a white paper from the International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab. 2016;36:665-680.
39. MacKay CM, Skow RJ, Tymko MM, Boulet LM, Davenport MH, Steinback CD, Ainslie PN, Lemieux CCM, Day TA. Central respiratory chemosensitivity and cerebrovascular CO2 reactivity: a rebreathing demonstration illustrating integrative human physiology. Adv Physiol Educ. 2016;40:79-92.
40. Boulet LM, Tymko MM, Jamieson AN, Ainslie PN, Skow RJ, Day TA. Influence of prior hyperventilation duration on respiratory chemosensitivity and cerebrovascular reactivity during modified hyperoxic rebreathing. Exp Physiol. 2016;101:821-835.
41. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
42. Rickards CA, Ryan KL, Cooke WH, Convertino VA. Tolerance to central hypovolemia: the influence of oscillations in arterial pressure and cerebral blood velocity. J Appl Physiol. 2011;111:1048-1058.
43. Zhang R, Levine BD. Autonomic ganglionic blockade does not prevent reduction in cerebral blood flow velocity during orthostasis in humans. Stroke. 2007;38:1238-1244.
44. Bailey DM, Rasmussen P, Overgaard M, Evans KA, BohmAM, Seifert T, Brassard P, Zaar M, Nielsen HB, Raven PB, Secher NH. Nitrite and S-nitrosohemoglobin exchange across the human cerebral and femoral circulation: relationship to basal and exercise blood flow responses to hypoxia. Circulation. 2017;135:166-176.
45. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
46. Birch AA, Dirnhuber MJ, Hartley-Davies R, Iannotti F, Neil-Dwyer G. Assessment of autoregulation by means of periodic changes in blood pressure. Stroke. 1995;26:834-837.
47. Brassard P, Kim Y-S, van Lieshout J, Secher NH, Rosenmeier JB. Endotoxemia reduces cerebral perfusion but enhances dynamic cerebrovascular autoregulation at reduced arterial carbon dioxide tension. Crit Care Med. 2012;40:1873-1878.
48. Yang J, Noyan-Ashraf MH, Meissner A, Voigtlaender-Bolz J, Kroetsch JT, Foltz W, Jaffray D, Kapoor A, Momen A, Heximer SP, Zhang H, van Eede M, Henkelman RM, Matthews SG, Lidington D, Husain M, Bolz SS. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-a-dependent activation of sphingosine-1-phosphate signaling. Circulation. 2012;126:196-206.
49. Meloche J, Pflieger A, Vaillancourt M, Paulin R, Potus F, Zervopoulos S, Graydon C, Courboulin A, Breuils-Bonnet S, Tremblay E, Couture C, Michelakis ED, Provencher S, Bonnet S. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation. 2014;129:786-797.
50. Chen J, Tang H, Sysol JR, Moreno-Vinasco L, Shioura KM, Chen T, Gorshkova I, Wang L, Huang L, Usatyuk PV, Sammani S, Zhou G, Raj JU, Garcia JGN, Berdyshev E, Yuan JX-J, Natarajan V, Machado RF. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2014;190:1032-1043.
51. Malenfant S, Neyron AS, Paulin R, Potus F, Meloche J, Provencher S, Bonnet S. Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ. 2013;3:278-293.
52. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1473-R1495.
53. Kanjhan R, Pow DV, Noakes PG, Bellingham MC. The two-pore domain K+ channel TASK-1 is closely associated with brain barriers and meninges. J Mol Histol. 2010;41:315-323.
54. Boucherat O, Chabot S, Antigny F, Perros F, Provencher S, Bonnet S. Potassium channels in pulmonary arterial hypertension. Eur Respir J. 2015;46:1167-1177.
55. Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, Ranchoux B, Jourdon P, Girerd B, Montani D, Provencher S, Bonnet S, Simonneau G, Humbert M, Perros F. Potassium-channel subfamily Kmember 3 (KCNK3) contributes to the development of pulmonary arterial hypertension. Circulation. 2016;133:1371-1385.
56. Naeije R, van de Borne P. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J. 2009;34:792-794.
57. Vicenzi M, Deboeck G, Faoro V, Loison J, Vachiery JL, Naeije R. Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension. Int J Cardiol. 2016;202:736-740.
58. Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C, Jaïs X, Sitbon O, Simonneau G, Similowski T, Garcia G. Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2015;45:1495-1498.
59. Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L, Sitbon O, Simonneau G, Humbert M, Similowski T. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2013;41:578-587.
60. Deboeck G, Niset G, Lamotte M, Vachiéry JL, Naeije R. Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J. 2004;23:747-751.
61. Kim MB, Ward DS, Cartwright CR, Kolano J, Chlebowski S, Henson LC. Estimation of jugular venous O2 saturation from cerebral oximetry or arterial O2 saturation during isocapnic hypoxia. J Clin Monit Comput. 2000;16:191-199.
62. Mar PL, Nwazue V, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Loyd JE, Hemnes AR, Robbins IM, Robertson D, Raj SR, Austin ED. Valsalva maneuver in pulmonary arterial hypertension: susceptibility to syncope and autonomic dysfunction. Chest. 2016;149:1252-1260.
63. Smith KJ, MacLeod D, Willie CK, Lewis NCS, Hoiland RL, Ikeda K, Tymko MM, Donnelly J, Day TA, MacLeod N, Lucas SJE, Ainslie PN. Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery. J Physiol. 2014;592:5507-5527.
64. Goodall S, Gonzélez-Alonso J, Ali L, Ross EZ, Romer LM. Supraspinal fatigue after normoxic and hypoxic exercise in humans. J Physiol. 2012;590:2767-2782.
65. Almeida OP, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Flicker L. Cognitive and brain changes associated with ischaemic heart disease and heart failure. Eur Heart J. 2012;33:1769-1776.
66. Vogels RLC, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail. 2007;9:1003-1009.
67. Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, Seshadri S, Gona P, Salton CJ, DeCarli C, O'Donnell CJ, Benjamin EJ, Wolf PA, Manning WJ. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation. 2010;122:690-697.
68. Peebles KC, Richards AM, Celi L, McGrattan K, Murrell CJ, Ainslie PN. Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gases. J Appl Physiol. 2008;105:1060-1068.
69. Serrador JM, Picot PA, Rutt BK, Shoemaker JK, Bondar RL. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke. 2000;31:1672-1678.
70. Coverdale NS, Gati JS, Opalevych O, Perrotta A, Shoemaker JK. Cerebral blood flow velocity underestimates cerebral blood flow during modest hypercapnia and hypocapnia. J Appl Physiol. 2014;117:1090-1096.
71. Verbree J, Bronzwaer AS, Ghariq E, Versluis MJ, Daemen MJ, van Buchem MA, Dahan A, van Lieshout JJ, van Osch MJP. Assessment of middle cerebral artery diameter during hypocapnia and hypercapnia in humans using ultra-high-field MRI. J Appl Physiol. 2014;117:1084-1089.
72. Ogoh S, Dalsgaard MK, Secher NH, Raven PB. Dynamic blood pressure control and middle cerebral artery mean blood velocity variability at rest and during exercise in humans. Acta Physiol (Oxf). 2007;191:3-14.
73. Tzeng YC, Chan GSH, Willie CK, Ainslie PN. Determinants of human cerebral pressure-flow velocity relationships: new insights from vascular modelling and Ca2+ channel blockade. J Physiol. 2011;589:3263-3274.
74. Ogoh S, Nakahara H, Ueda S, Okazaki K, Shibasaki M, Subudhi AW, Miyamoto T. Effects of acute hypoxia on cerebrovascular responses to carbon dioxide. Exp Physiol. 2014;99:849-858.
75. Rosengarten B, Schermuly RT, Voswinckel R, Kohstall MG, Olschewski H, Weissmann N, Seeger W, Kaps M, Grimminger F, Ghofrani HA. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension. Cerebrovasc Dis. 2006;21:194-200.